A Study of DNL310 in Pediatric Participants With Hunter Syndrome
Mucopolysaccharidosis II MPS II Hunter Syndrome nMPS II Mucopolysaccharidoses DNL310
Lead Scientist at University of California Health
- Paul Harmatz, MD (ucsf)
Professor, Pediatrics. Authored (or co-authored) 195 research publications.
- accepting new patients
- Start Date
- Completion Date
- Denali Therapeutics Inc.
- Phase 1/2
- Study Type
- Last Updated